Targacept and AstraZeneca’s drug failed in its first late-stage clinical trial, the companies developing the drug said Tuesday.
Shares of the drug’s main developer, Targacept, plunged 57 percent in early trading Tuesday morning to $8.23. AstraZeneca paid $200 million up front in a deal announced in 2009 for rights to the drug, known as TC-5124.
What a shame – not!
Crack. Fizz. Gulp. Ahhhhhh. Is there a drinking experience more classically Australian than ripping the ring-pull off a beer? "The visceral pleasure from that first crack of a beer can is identical to popping a champagne cork," says wine and drinks writer Mike Bennie. "There's also huge appeal in the tinnie's nostalgia factor."
The Control of Tobacco Products and Electronic Delivery Systems Bill (‘Tobacco Bill’), which is open for comment until 9 August 2018, imposes draconian new rules and restrictions on the sale and use of tobacco products, and controversially places electronic delivery systems (e-cigarettes or “vapes”) under harsh regulation.
The Milwaukee Bucks will designate as non-smoking not only the new Fiserv Forum but also the entire 30-acre arena district. This ban includes e-cigarettes.
0 Comments